Instead, a cautious 'low and slow' approach is strongly advised by neuro-immune specialists
Abstract Although iron accumulates in brain regions impacted by neurodegenerative diseases such as Alzheimers and Parkinsons, how chronic elevated iron levels contribute to neuronal dysfunction remains unclear
FDA scientists remain unconvinced of peptide safety and benefits In recent years, the FDA has warned Americans about the risks of injecting peptides like BPC-157 and TB-500, another compound set for review Thursday
may be diffuse Rectal bleeding more common in colonic Crohns
CagriSema, as of mid-2026, has completed its Phase 3a REDEFINE program but is not approved by the FDA, the EMA, or any other regulator, and its benefitrisk profile is still under review
Brain Sciences, 11 (3)